MENU
+Compare
BEAT
Stock ticker: NASDAQ
AS OF
Jun 26, 04:58 PM (EDT)
Price
$1.40
Change
-$0.02 (-1.41%)
Capitalization
57.13M

BEAT Heartbeam Forecast, Technical & Fundamental Analysis

HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting... Show more

BEAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for BEAT with price predictions
Jun 25, 2025

BEAT's Stochastic Oscillator sits in oversold zone for 3 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where BEAT advanced for three days, in of 149 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 09, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on BEAT as a result. In of 61 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for BEAT turned negative on June 17, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 30 similar instances when the indicator turned negative. In of the 30 cases the stock turned lower in the days that followed. This puts the odds of success at .

BEAT moved below its 50-day moving average on June 17, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BEAT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BEAT broke above its upper Bollinger Band on June 02, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for BEAT entered a downward trend on June 09, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.586) is normal, around the industry mean (31.764). P/E Ratio (149.254) is within average values for comparable stocks, (163.927). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.724). Dividend Yield (0.000) settles around the average of (0.030) among similar stocks. P/S Ratio (5.999) is also within normal values, averaging (61.726).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. BEAT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BEAT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

View a ticker or compare two or three
BEAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

BEAT is expected to report earnings to fall 11.11% to -15 cents per share on August 07

Heartbeam BEAT Stock Earnings Reports
Q2'25
Est.
$-0.16
Q1'25
Missed
by $0.02
Q4'24
Missed
by $0.56
Q3'24
Missed
by $0.04
Q2'24
Missed
by $0.02
The last earnings report on May 13 showed earnings per share of -18 cents, missing the estimate of -15 cents. With 90.45K shares outstanding, the current market capitalization sits at 57.13M.
A.I. Advisor
published General Information

General Information

a wireless medical technology company, which focuses on the delivery of health information

Industry PackagedSoftware

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
2118 Walsh Avenue
Phone
+1 408 899-4443
Employees
15
Web
https://www.heartbeam.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MTC0.950.03
+3.12%
MMTec Inc
NKE60.83-0.59
-0.96%
Nike
COHU19.48-0.19
-0.97%
Cohu
TNET72.97-2.16
-2.88%
Trinet Group
ICCC6.14-0.74
-10.78%
ImmuCell Corp

BEAT and Stocks

Correlation & Price change

A.I.dvisor tells us that BEAT and SNOW have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BEAT and SNOW's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAT
1D Price
Change %
BEAT100%
-4.05%
SNOW - BEAT
33%
Poorly correlated
-0.73%
ALKT - BEAT
30%
Poorly correlated
-4.74%
FICO - BEAT
29%
Poorly correlated
-1.72%
APPN - BEAT
29%
Poorly correlated
-2.39%
ZS - BEAT
29%
Poorly correlated
+1.14%
More